SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-040265
Filing Date
2021-06-14
Accepted
2021-06-14 16:56:47
Documents
1
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4107
  Complete submission text file 0001209191-21-040265.txt   5530
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Issuer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FORTE BIOSCIENCES, INC. 1124 W. CARSON ST., MRL BLDG 3-320 TORRANCE CA 90502
Business Address
Eichenfield Lawrence (Reporting) CIK: 0001814892 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38529 | Film No.: 211015240